FutureCeuticals Expands Momence, Illinois, Operations
01/23/2017
FutureCeuticals develops fruit, vegetable, and grain-based powders and extracts for food ingredients, dietary supplements, cosmetics and healthcare products, and conducts R&D for Van Drunen Farms. Incorporated in 1999, the company contracts with food, beverage, dietary supplements and pharmaceutical companies worldwide.
According to the company, which holds more than 50 patents for functional food ingredients, the additional space will house its 50 to 60 member sales, customer service and marketing force. Another 20 to 30 employees are expected to be hired within the next 12 to 24 months. The expansion is expected to be complete by July.
Together, FutureCeuticals and sister company Van Drunen Farms, the leading producer of organic culinary herbs in the United States, own and operate 670,000 square feet of manufacturing, storage, R&D, sales and administrative space in nine Momence facilities, officials said. The company's’ total employment has nearly doubled in six years, from 370 workers in 2010 to 680 today.
Project Announcements
Utilidata Expands Ann Arbor, Michigan, Operations
02/05/2026
Wilbur Products-MOTIV Bowling Expands Roosevelt Park, Michigan, Operations
02/05/2026
InnovAsian Cuisine Enterprises Plans Jonesboro, Arkansas, Production Operations
02/04/2026
Siemens Energy Plans Pearl, Mississippi, Electric Grid Component Operations
02/04/2026
The Shaw Group Expands Walker, Louisiana, Operations
02/04/2026
Italy-Based Huwell US Plans Cherokee County, South Carolina, Operations
02/04/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025